Morinaga&Co (2201) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
15 Oct, 2026Executive summary
April–December delivered record net sales and profit at all levels; sales growth, price revisions and U.S. gains helped offset raw-material cost pressure.
Full-year forecasts were raised, with accelerated Q4 investment planned to support medium- to long-term growth.
Financial highlights
9M net sales were ¥163.8B, up 10.8% YoY; gross profit rose 14.3% to ¥67.9B and SG&A rose 5.6% to ¥48.2B.
Operating income increased 43.2% to ¥19.7B, ordinary income rose 44.2% to ¥20.2B, and parent-attributable profit grew 57.9% to ¥14.0B.
Simplified EBITDA rose 25.5% to ¥26.7B; extraordinary income was ¥1.3B and extraordinary losses were ¥1.9B, including ¥1.6B in impairment losses.
Overseas sales increased 30.0% to ¥21.0B, lifting their share of consolidated sales to 12.8% from 10.9%.
Outlook and guidance
Full-year forecast: net sales ¥211.0B, operating income ¥19.5B, ordinary income ¥20.15B and parent-attributable profit ¥14.2B; sales and profit forecasts were raised from November.
Forecast gross margin is 40.8%, operating margin 9.2% and simplified EBITDA ¥29.0B; the forecast assumes ¥140.56 per U.S. dollar.
Forecast increases reflect domestic confectionery and frozen-dessert growth, sales momentum and price revisions, alongside accelerated investment in businesses and foundations for long-term growth.
Year-end dividend forecast rose to ¥55 per share from ¥52.50; forecast payout ratio is 30.0%.
Latest events from Morinaga&Co
- Q1 earnings rose on U.S. growth and price revisions; FY2024 guidance was unchanged.2201
Q1 2024 - Record first-half sales lifted guidance, while second-half investment is expected to weigh on profit.2201
Q2 2024 - Record FY2023 sales and profit growth, with FY2024 growth forecast amid cost headwinds.2201
Q4 2024 - Q1 sales rose 11.4%; a US$136 million U.S. factory will expand HI-CHEW capacity.2201
Q1 2025 - Record H1 sales and higher FY2025 guidance despite cost-pressured operating income.2201
Q2 2025 - 9M sales grew 7.8%, but raw-material inflation pressured earnings; FY2025 forecasts held.2201
Q3 2025 - FY2025 sales hit a record, while cacao inflation and cash outflows tempered gains.2201
Q4 2025 - H1 operating income fell 3.7%, but FY2026 operating-income guidance rose to ¥22.3bn.2201
Q2 2026 - Core sweets growth and MyMo expansion offset by near-term acquisition costs.2201
Q4 2026